Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug

These healthcare stocks are up more than 400% in the past five years, thanks to their dominance in the anti-obesity market.Eli Lilly (LLY -3.36%) and Novo Nordisk (NVO -3.75%) are the two big names dominating the anti-obesity market today. They've been generating billions in revenue from their treatments, and there's still a lot of growth for these companies.However, the weight loss drug that proves to be more effective could ultimately determine which company will capture the lion's share of the market. Th ...